Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review

JAMA oncology

Volumn 2, Issue 10, 2016, Pages 1354-1360

  Stanton, Sasha E ^a   Adams, Sylvia ^a   Disis, Mary L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

CD8+ T LYMPHOCYTE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOLOGY; INCIDENCE; METABOLISM; PROGNOSIS; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR ASSOCIATED LEUKOCYTE;

BIOMARKERS, TUMOR; CD8-POSITIVE T-LYMPHOCYTES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; LYMPHOCYTES, TUMOR-INFILTRATING; PROGNOSIS; RECEPTOR, ERBB-2; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 85013841114     PISSN: None     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2016.1061     Document Type: Review

References (0)